Skip to Content
  • Article
  • Open Access

3 September 2021

22 Pages

Canady Helios Cold Plasma Induces Breast Cancer Cell Death by Oxidation of Histone mRNA

,
,
,
,
,
,
,
and
1
Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Takoma Park, MD 20912, USA
2
School of Medicine, University of Massachusetts, Worcester, MA 01605, USA
3
Department of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, USA
4
Microbiology Department, Howard University, Washington, DC 20060, USA

Abstract

Breast cancer is the most common cancer among women worldwide. Its molecular receptor marker status and mutational subtypes complicate clinical therapies. Cold atmospheric plasma is a promising adjuvant therapy to selectively combat many cancers, including breast cancer, but not normal tissue; however, the underlying mechanisms remain unexplored. Here, four breast cancer cell lines with different marker status were treated with Canady Helios Cold Plasma™ (CHCP) at various dosages and their differential progress of apoptosis was monitored. Inhibition of cell proliferation, induction of apoptosis, and disruption of the cell cycle were observed. At least 16 histone mRNA types were oxidized and degraded immediately after CHCP treatment by 8-oxoguanine (8-oxoG) modification. The expression of DNA damage response genes was up-regulated 12 h post-treatment, indicating that 8-oxoG modification and degradation of histone mRNA during the early S phase of the cell cycle, rather than DNA damage, is the primary cause of cancer cell death induced by CHCP. Our report demonstrates for the first time that CHCP effectively induces cell death in breast cancer regardless of subtyping, through histone mRNA oxidation and degradation during the early S phase of the cell cycle.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.